相关实验视频
Updated: Jan 8, 2026

08:56
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
1.2K
斯基桑德罗B通过向TRAF6-NOX1通路来抑制骨质细胞形成并减轻雌激素缺乏引起的骨损失
Yuangang Su1, Jiamin Liang1, Haoyu Lian1
1Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, 530021, China.
概括
斯基桑德罗B (SolB) 通过减少氧化应激和向关键信号通路,有效地抑制骨质细胞形成和骨再吸收. 这种天然化合物在骨质疏松症模型中有望预防骨质损失.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨质疏松症的特点是骨质细胞活性增加和骨质再吸收.
- 向骨质细胞生成是骨质疏松症治疗的关键策略.
- 斯基桑德罗B (SolB) 对骨质细胞和骨质疏松症的影响尚不清楚.
研究的目的:
- 为了研究SolB对骨质细胞的抑制作用.
- 确定SolB在预防雌激素缺乏引起的骨质疏松症方面的有效性.
主要方法:
- 在实验室测试中评估了骨质细胞生成,F-actin环形成,骨再吸收,细胞内活性氧物种 (ROS) 和抗氧化酶.
- 转录组分析确定了SolB对RANKL介导的信号通路的影响.
- 分子对接,动力学和表面等离子体共振 (SPR) 证实了SolB与标蛋白结合.
- 一个卵巢切除 (OVX) 的小鼠模型评估了SolB对骨质的保护作用.
主要成果:
- SolB通过增强抗氧化酶,减少细胞内ROS,Ca2+和NFATc1表达来抑制骨质细胞的产生和骨质再吸收.
- SolB抑制了RANKL诱导的TRAF6-NF-κB和MAPK信号通路的激活.
- SPR证实了SolB与TRAF6和NOX1.1的结合.
- 通过减少NOX1的表达和增加抗氧化酶的表达,SolB治疗保护了OVX小鼠的骨质损失.
结论:
- SolB显示出作为预防和治疗绝经后骨质疏松症的有效治疗剂的潜力.
- SolB的机制涉及调节氧化应激和关键信号通路,涉及骨质细胞形成.
相关概念视频
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
